Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)Business Wire • 06/28/24
Global Bioreactors Market Forecast Report 2024-2035 with Key Players Profiles of Applikon Biotechnology, Bionet, Cytiva, Eppendorf, Merck, Sartorius, Solaris Biotech, Solida Biotech and LABAOGlobeNewsWire • 06/28/24
CDC'S ACIP Unanimously Recommends Merck's CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate AdultsBusiness Wire • 06/28/24
Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party ManufacturerBusiness Wire • 06/26/24
USDA Approves Merck Animal Health's NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine InfluenzaBusiness Wire • 06/25/24
Forget Nvidia: Prominent Billionaires Are Selling It in Favor of These 7 Top-Notch StocksThe Motley Fool • 06/25/24
Merck (MRK) Increases Despite Market Slip: Here's What You Need to KnowZacks Investment Research • 06/24/24
Merck Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck CancerBusiness Wire • 06/24/24
With Robust AI Prospects Is IBM A Better Pick Over Merck Stock Within The Dow Index?Forbes • 06/24/24
U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in AdultsBusiness Wire • 06/17/24
FDA Approves Merck's KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial CarcinomaBusiness Wire • 06/17/24
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infectionsCNBC • 06/17/24